Aligos Therapeutics to Present Data on pan-Coronavirus Protease Inhibitors for the Treatment of ...
bdtonline.com
news
2022-10-18 11:33:30

SOUTH SAN FRANCISCO, Calif., Oct. 18, 2022 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, the 'Company'), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet medical needs in viral and liver diseases, today announced that the Company will make an oral presentation at the Cambridge Healthtech Institute's 20th Annual Discovery on Target Conference being held October 17-20, 2022 in Boston, MA. In the presentation, Aligos will review its progress towards the development of broadly-acting, orally available small molecule protease inhibitors to address COVID-19, regardless of the strain.
